Maria Kavallaris Selected Research

Maria Kavallaris Research Topics

Disease

72	Neoplasms (Cancer) 01/2022 - 09/2002
27	Neuroblastoma 01/2022 - 07/2003
13	Leukemia 11/2021 - 07/2003
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 11/2003
8	Breast Neoplasms (Breast Cancer) 12/2021 - 07/2003
8	Neoplasm Metastasis (Metastasis) 01/2020 - 08/2010
7	Carcinogenesis 01/2022 - 07/2003
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016 - 10/2007
5	Lung Neoplasms (Lung Cancer) 07/2021 - 12/2008
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 01/2014
3	Glioblastoma (Glioblastoma Multiforme) 12/2022 - 10/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 05/2010
2	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2021
2	Adenocarcinoma 01/2021 - 02/2015
2	Medulloblastoma 12/2020 - 01/2020
2	Communicable Diseases (Infectious Diseases) 01/2019 - 06/2005
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2018 - 01/2017
2	Triple Negative Breast Neoplasms 12/2014 - 10/2011
2	Hypersensitivity (Allergy) 05/2010 - 12/2008
2	Disease Progression 07/2008 - 05/2007
1	Drug-Related Side Effects and Adverse Reactions 12/2021
1	Philadelphia Chromosome 11/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021
1	Diffuse Intrinsic Pontine Glioma 03/2021
1	Choristoma (Ectopic Tissue) 01/2021

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2003
26	Pharmaceutical PreparationsIBA 12/2020 - 06/2003
25	TubulinIBA 01/2022 - 09/2002
14	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2006
8	Biological ProductsIBA 01/2021 - 06/2007
8	PolymersIBA 01/2019 - 02/2008
7	Dextrans (Dextran)FDA Link 01/2018 - 11/2012
6	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 11/2003
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2011
5	RetinoidsIBA 08/2015 - 07/2003
5	Vinca AlkaloidsIBA 12/2008 - 09/2002
4	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2014
4	CopperIBA 10/2020 - 01/2016
4	Antimitotic AgentsIBA 01/2020 - 09/2002
4	Catechin (Z 7300)IBA 01/2018 - 06/2014
4	AlkaloidsIBA 01/2017 - 11/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 10/2006
3	Silicon Dioxide (Silica)FDA LinkGeneric 12/2022 - 10/2021
3	Microtubule ProteinsIBA 01/2022 - 09/2004
3	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2018
3	LuciferasesIBA 07/2021 - 10/2011
3	Messenger RNA (mRNA)IBA 10/2020 - 12/2011
3	Copper Transporter 1IBA 10/2020 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 10/2007
3	Antineoplastic Agents (Antineoplastics)IBA 11/2016 - 10/2011
3	Vinblastine (Vinblastine Sulfate)FDA Link 04/2016 - 11/2003
3	Actins (F Actin)IBA 01/2015 - 03/2006
3	desoxyepothilone B (epothilone D)IBA 11/2011 - 07/2003
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 11/2011
2	Polysaccharides (Glycans)IBA 01/2022 - 11/2011
2	StathminIBA 01/2022 - 01/2020
2	taxaneIBA 12/2021 - 10/2011
2	Long Noncoding RNAIBA 10/2021 - 07/2014
2	HydrogelsIBA 01/2021 - 03/2017
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 07/2008
2	Peptides (Polypeptides)IBA 12/2020 - 01/2020
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 01/2018
2	Colchicine FDA LinkGeneric 01/2020 - 09/2004
2	AntibodiesIBA 01/2019 - 07/2003
2	PolyphenolsIBA 01/2017 - 01/2016
2	Propranolol (Inderal)FDA LinkGeneric 04/2016 - 10/2011
2	Drug CombinationsIBA 12/2014 - 10/2011
2	Antisense OligonucleotidesIBA 07/2014 - 09/2003
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 05/2007
2	Tripartite Motif ProteinsIBA 03/2013 - 02/2012
2	Epothilones (Epothilone)IBA 10/2011 - 07/2003
2	epothilone B (EPO906)IBA 01/2011 - 10/2006
2	retinoic acid receptor betaIBA 05/2009 - 06/2006
2	ProteomeIBA 11/2003 - 06/2003
1	Complement System Proteins (Complement)IBA 12/2021
1	Thymic Stromal LymphopoietinIBA 11/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 11/2021
1	Immunoglobulin FragmentsIBA 11/2021
1	LactoferrinIBA 10/2021
1	Lipid NanoparticlesIBA 10/2021
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 07/2021
1	Docetaxel (Taxotere)FDA Link 07/2021
1	DisulfidesIBA 07/2021
1	EmulsionsIBA 07/2021
1	GoldIBA 03/2021
1	RNA Helicases (RNA Helicase)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	CardiotoxinsIBA 01/2021
1	Blocking AntibodiesIBA 10/2020
1	Death Domain ReceptorsIBA 10/2020
1	Chelating AgentsIBA 10/2020
1	B7-H1 AntigenIBA 10/2020
1	Protein Isoforms (Isoforms)IBA 02/2020
1	perifosineIBA 02/2020
1	Glutamine (L-Glutamine)FDA Link 01/2020

Therapy/Procedure

24	Therapeutics 01/2022 - 06/2005
24	Drug Therapy (Chemotherapy) 01/2022 - 06/2003
3	Radiotherapy 01/2020 - 01/2017
2	Precision Medicine 01/2019 - 01/2014